DAFTAR PUSTAKA

Kearney, PM, Whelton, M, Reynolds, K, Muntner, P, Whelton, PK, He, J 2005,

Global burden of hypertension: analysis of worldwide data, Lancet ; 365:217223, www.ncbi.nlm.nih.gov/pubmed/15652604
1. Badan Penelitian dan Pengembangan Kesehatan 2013, Riset Kesehatan Dasar
(Riskesdas 2013), Kementerian Kesehatan Republik Indonesia, Jakarta,
http://www.depkes.go.id/resources/download/general/Hasil%20Riskesdas
%202013
2. Hadyanto L. (2009). Farmakologi kardiovaskuler, edisi ke-2, PT. Sofmedia,
Jakarta
3. Olver NI. Xerostomia: A common adverse effects of drugs and radiation. Aust
prescr 2006; 29: 97. http://www.australianprescriber.com/magazine/29/4/97/8
4. Nefendors T, Dahlof C. Effect of the beta-adrenoreseptor antagonis atenolol and
propranolol on human whole saliva flow rate composition. Scan J Dent Rest
1994; 102(4): 235-7. http://www.ncbi.nlm.nih.gov/pubmed/1280091
5. Almeida PDVd, Gregio AMT, Marchado MAN, de Lima AAS, Azevedo LR.
Saliva function composition. The Journal of contemporary dental practice 2008;
9(3):
1-11.
https://www.unc.edu/courses/2008ss2/obio/720/001/2008_Readings/070308_saliv
a_review.pdf
6.

Lubis S, Tarigan RN, Lubis I. Penyakit-penyakit kelenjar ludah. Medan: USU

Press, 2011: 84-92.

7.

Fox PC. (2008). Xerostomia. ADHassosiation, Supplement to Access, hlm.

1-3.

8.

Naviille BW, DAMM DD, Allen CM, Bouquot JE. Oral and maxillofacial
pathology.
3rd
ed.,
China:
Saunders
Elsevier,
2009:
464-65.
http://me2.do/xkiN6OIr

9.

Scully C. Oral and maxillofacial medicine. 2nd ed., London: Churchill Living
Stone Elsivier, 2010: 79-86.

Stipetic MM. Xerostomia diagnosis and treatment. Ras514 Medical Science 2012;
38: 69-91. http://hrcak.srce.hr/file/134991
10.

Gayford JJ, Heskell R. Penyakit mulut. Edisi 2. drg Lilian Yuwono. Jakarta:
EGC, 1993: 169-76.

11.

Guggenheimer (2003). Xerostomia : Etiology, recognition and treatment. J

Am
Dent
Assoc,
Vol
134,
No
1,
61-69.
http://www.ncbi.nlm.nih.gov/pubmed/12555958

Indriyani M. (2010). Penanganan keluhan selain nyeri. Rumah Kanker, Surabaya

12.

Aronson JK.Side effects of cardiovascular drugs.Oxford:Elsevier BV

2009;11-30.

13.

Torpet LA, Kragelund C, Reibel J, Nauntofte B. Oral adverse drug reactions

to
cardiovascular
drugs.
CROBM
2004:
28-45.
http://cro.sagepub.com/content/15/1/28.full.pdf+html

14.

Sham ME. Xerostomia. International Journal of Dental Clinic 2011; 3(2): 5861. http://intjdc.com/index.php/intjdc/article/viewFile/15.3.2.11/pdf

15.

Rantonen P. Salivary flow and composition in healthy and diseased adults.

Disertasi.
Helsinki:
University
of
Helsinki,
2003:
12-13.
https://core.ac.uk/download/files/555/14915842.pdf

16.

Joewono BS, Prabowo P. Ilmu penyakit jantung. Surabaya: Airlangga

University Press, 2003: 121-34.

17.

Visvanathan V, Nix P (2010). Managing the patient presenting with

xerostomia:
a
review.
Int
J
Clin
Pract,
64(3):404-407.
http://www.ncbi.nlm.nih.gov/pubmed/19817913

18.

Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA, Izzo, JL,
Jr et al 2003. ;The seventh report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure: The JNC
7 Report.
JAMA;289:256072,
http://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdf

19.

Silbernagl, S & Lang, F 2009, Color Atlas of Pathophysiology, New York :

Thieme Medical Publishers.

20.

Departemen Farmakologi dan Terapeutik Fakultas Kedokteran Universitas

Indonesia. Farmakologi dan terapi. Edisi 5. Jakarta: Gaya Baru, 2007: 362-72

21.

Schmitz, Gery. 2008, Farmakologi dan toksikologi, Penerjemah : Luki

Setiadi, Penerbit buku kedokteran EGC, Jakarta.